Rocket
Premium
Excel Add-In
International
Tools
Dashboard
Screener
Spinoffs
IPOs
Register
Alerts
Sign In
News + Filings
Key Docs
Ownership
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Viracta Subsidiary, Inc. (VIRX)
Create:
Alert
All
|
News
|
Filings
Date Filed
Type
Description
01/10/2023
SC 13D/A
Schindel Yair Chaim reports a 19.4% stake in Viracta Therapeutics, Inc.
03/10/2021
D
Form D - Notice of Exempt Offering of Securities:
03/03/2021
SC 13G
LVP LIFE SCIENCE VENTURES III L.P. reports a 8.4% stake in Viracta Therapeutics, Inc.
03/01/2021
SC 13D
Form SC 13D - General statement of acquisition of beneficial ownership:
12/10/2020
D
Form D - Notice of Exempt Offering of Securities:
11/05/2019
D
Form D - Notice of Exempt Offering of Securities:
02/12/2019
D
Form D - Notice of Exempt Offering of Securities:
02/12/2019
D/A
Form D/A - Notice of Exempt Offering of Securities: [Amend]
12/13/2018
D
Form D - Notice of Exempt Offering of Securities:
07/02/2018
D
Form D - Notice of Exempt Offering of Securities:
04/05/2017
D
Form D - Notice of Exempt Offering of Securities
01/09/2009
REGDEX/A
Form REGDEX/A -- Notice of Sale of Securities [Regulation D and Section 4(6) of the Securities Act of 1933] [amend]
Rocket Data Systems, Inc. © 2019 |
Contact Us
|
Data Disclaimer
|
Terms of Use
|
Privacy